
Answered Instantly!
Sell-side advisory | Behavioral Health | Substance Use Disorder Treatment
Polaris Detox LLC, doing business as Innovo Detox, is a Pennsylvania-based provider of substance use disorder (SUD) and drug and alcohol rehabilitation services. Innovo built a strong reputation for clinical quality and patient care, delivering residential and clinical treatment services to patients across the region.

Innovo’s founder, Eric Spofford, was looking for the right partner to carry the organization into its next phase of growth: a buyer that shared Innovo’s commitment to high-quality addiction treatment and had the platform to support it. He engaged M&A Healthcare Advisors as Innovo’s exclusive sell-side advisor to run the process.
Behavioral health transactions bring a set of challenges that generalist advisors are rarely equipped to handle. Buyers in the SUD space evaluate licensing and regulatory considerations, the complexities of commercial insurance reimbursement, and the clinical operations behind the financials. This transaction also required careful structuring to present Innovo as a clean, standalone acquisition, while keeping a complex process moving on an accelerated timeline.
MAHA’s team, led by Andre Ulloa, Partner and Managing Director, and Mike Abud, Senior Advisor, managed every phase of the engagement:
— Buyer identification: MAHA identified R&S Holdings Inc. dba Project Chesapeake early in the process as a strong strategic fit, given its commitment to the substance use disorder sector and its vision for a quality behavioral health platform in the Mid-Atlantic region.
— Diligence management: MAHA coordinated a comprehensive diligence process, organizing financial, operational, and clinical information so the buyer could evaluate the business with confidence.
— Deal execution: MAHA worked closely with legal counsel on both sides to maintain momentum, address issues as they arose, and keep the transaction on schedule.
— Relationship management: Throughout the process, MAHA worked daily to facilitate communication between buyer and seller and foster a productive working relationship.
"
“M&A Healthcare Advisors ran our process with precision and a real command of every detail. They understood the clinical and regulatory realities of the business, kept a complicated transaction moving on a quick timeline, and consistently protected our position at the table. When it came time to close, they delivered. I would work with them again.”
Eric Spofford, Founder, Innovo Detox
M&A Healthcare Advisors is a FINRA-licensed investment bank focused exclusively on the healthcare industry, with deep experience in behavioral health and substance use disorder treatment. Contact us for a confidential conversation about your goals.